Rituximab, a lower-cost treatment, may be as effective at managing RRMS as the approved therapy Ocrevus, a new study from ...

An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Depression and anxiety have been well documented in people with multiple sclerosis (MS), but often are undiagnosed or ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called ...

Columnist Desiree Lama shares what she wishes she'd been told after her diagnosis of multiple sclerosis at age 17.

Keeping up with scientific advances and practice changes can be one the biggest challenges in managing a complex disease like multiple sclerosis (MS).

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...

A University of Alberta study shows that rural Albertans living with multiple sclerosis are not as likely as urban patients ...